Searched for
SOLARA
Stocks in news: Godrej Properties, Whirlpool, Solara Active Pharma, TCS, Nestle IndiaBandhan Bank reported a net profit of Rs 54.62 crore for the quarter ended March 2024, which was down from Rs 808 crore in the year ago per...- US FDA inspects Vishakhapatnam facility of Solara Active PharmaThe US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences' API manufacturing facility in Visakhapatna...
- Buy Solara Active Pharma Sciences, target price Rs 400: Motilal OswalSolara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 1249.61 Crore) operati...
- Buy Solara Active Pharma Sciences, target price Rs 520: ICICI SecuritiesSolara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 1604.35 Crore) operati...
- Buy Solara Active Pharma Sciences, target price Rs 488: ICICI SecuritiesSolara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 1364.98 Crore) operati...
- Add Solara Active Pharma Sciences, target price Rs 721: ICICI SecuritiesWhile the brokerage believes near-term performance would remain under pressure due to business volatility, cost inflation and withdrawal of...
- Biggest gainers & losers of the day: Solara Active Pharma drops 20%, Schneider zoomsSolara Active Pharma hit lower circuit for the second straight session. Coastal Corp tanked over weaker sentiments
- Solara Active Pharma hits fresh 52-week low, tumbles 35% in two sessionsThe API manufacturer reported a net loss of Rs 139.87 crore in the quarter ended December 2021 as against a net profit of Rs 65.80 crore du...
- Solara Active Pharma hits new 52-week low on reporting loss in Q3The chief executive officer (CEO) and chief operating officer (COO) stepped down from their position, which was accepted and approved by th...
- Buy Solara Active Pharma Sciences, target price Rs 1595: ICICI SecuritiesSolara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 3660.35 Crore) operati...
- Buy Solara Active Pharma Sciences, target price Rs 2050: Motilal OswalSolara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 6302.08 Crore) operati...
- After rallying 6 times in 3 years, this API maker just got first ‘sell’ ratingThe stock, which got listed at Rs 288 on June 27, 2018, hit a record high of Rs 1,859 on Wednesday, rising a solid 550 per cent, or 6.45 ti...
- Reclusive Mankekar makes a splash with Solara stakeThe Mumbai-based reclusive investor held nearly 4 per cent stake in Sequent Scientific till March 2018 and about 2.07 per cent in Strides P...
- Buy Solara Active Pharma Sciences, target price Rs 2000: Motilal OswalSolara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 5927.33 Crore) operati...
- BSE bulk deals: Aditya Birla MF buys stake in Solara Active PharmaTPS Growth Fund sold 1.33 million shares of Solara Active at Rs 1,557.3 apiece through a bulk deal on the BSE.
- NSE-BSE bulk deals: Scottish Oriental Trust buys stake in Solara ActiveScottish Oriental Smaller Companies Trust bought 199,259 shares of Solara Active Pharma at Rs 1,462.25 per share
- Solara Active Pharma Services' Vaidya settles alleged insider trading case with SebiHe has settled the matter "without admitting or denying the findings of fact and conclusions of law" after paying Rs 6.03 lakh towards sett...
- Solara promoter, TPG plan to sell stake in companyThe company has seen a near five-fold jump in its share price, giving promoters Kumar and his partner KR Ravishankar an additional reason t...
- NSE-BSE bulk deals: Ascent India Fund cuts stake in Solara Active PharmaAscent India Fund III sold 3,41,848 shares of Solara Active Pharma Sciences at Rs 1,212.64 per share. The fund held 2.11 per cent stake in ...
- Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall"We understand from Mylan NV's press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lo...
Load More
